Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function-Wan-Original Scan

The original western blot scans for the following manuscript: Wan L, Xu K, Wei Y, Zhang J, Han T, Fry C, Zhang Z, Wang YV, Huang L, Yuan M, Xia W, Chang WC, Huang WC, Liu CL, Chang YC, Liu J, Wu Y, Jin VX, Dai X, Guo J, Liu J, Jiang S, Li J, Asara JM, Brown M, Hung MC, Wei W. Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function. Mol Cell. 2018 Jan 18;69(2):279-291.e5. doi: 10.1016/j.molcel.2017.12.024. PubMed PMID: 29351847; PubMed Central PMCID: PMC5777296.本数据集对应下述论文的原始蛋白免疫印迹（western blot）扫描结果： 作者：Wan L、Xu K、Wei Y、Zhang J、Han T、Fry C、Zhang Z、Wang YV、Huang L、Yuan M、Xia W、Chang WC、Huang WC、Liu CL、Chang YC、Liu J、Wu Y、Jin VX、Dai X、Guo J、Liu J、Jiang S、Li J、Asara JM、Brown M、Hung MC、Wei W 《腺苷酸活化蛋白激酶（AMP-activated protein kinase, AMPK）磷酸化zeste基因增强子同源物2（Enhancer of Zeste Homolog 2, EZH2）抑制多梳抑制复合体2（Polycomb Repressive Complex 2, PRC2）甲基转移酶活性及致癌功能》 发表于《分子细胞（Molecular Cell）》，2018年1月18日；第69卷第2期，页码279-291.e5。DOI: 10.1016/j.molcel.2017.12.024；PubMed PMID: 29351847；PubMed Central PMCID: PMC5777296。